1. Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study. Issue 2 (28th January 2023) Authors: Nahi, Hareth; Usmani, Saad Z.; Mateos, Maria-Victoria; van de Donk, Niels W. C. J.; Oriol, Albert; Plesner, Torben; Bandyopadhyay, Nibedita; Hellemans, Peter; Tromp, Brenda; Nnane, Ivo; Zemlickis, Donna; Chari, Ajai; Moreau, Philippe Journal: Leukemia & lymphoma Issue: Volume 64:Issue 2(2023) Page Start: 468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗